Assessment of social and economic impact of healthcare with homoeopathy for haemophilia in cognizance with patients’ perspective: a cross-sectional survey
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20230620Keywords:
Economic, Haemophilia, Healthcare, Homoeopathy, SocialAbstract
Background: Haemophilia imposes clinical as well as an economical burden on family and society. To assess the social and economic impact of healthcare in haemophilia from patients’ perspective a questionnaire was formed. Out of 900 patients treated at homoeopathy in haemophilia centers, 478 patients participated in the survey in the time period of January 2017 to June 2017. This questionnaire consisted of five categories. Part A included preliminary information, part B included the disease information, part C included direct cost incurred in terms of factor therapy, and part D included indirect cost incurred whereas part E included additional information regarding therapy satisfaction.
Methods: It was a cross-sectional survey-based study. Simple random sampling was used for sample collection at the multicentres of homoeopathy in haemophilia. Study duration was 5 months. Selection criteria was patients diagnosed with haemophilia and patients willing to participate in the survey. Ethical approval was received from Institutional Ethics Committee of Motiwala (National) Homoeopathic Medical College, Nasik, Maharashtra, India. Average was calculated to summarize the data, mentioned in discussion.
Results: 56% haemophilia patients benefitted with homoeopathy treatment with SOS use of factor, 28% patients experienced homoeopathy is beneficial therapy and 16% patients experienced conservative management. 95.6% patients experienced satisfaction with treatment. 95.2% patient said homoeopathy is most economic therapy, 1.3% patient said it is a conservative management and 3.6% did not acknowledge anything.
Conclusions: According to patients’ perspective, homoeopathic therapy was found to reduce the cost of care and burden of high-cost management.
References
Berntorp E, Boulyjenkov V, Brettler D, Chandy M, Jones P, Lee C, et al. Modern treatment of haemophilia. Bull World Health Organ. 1995;73(5):691.
Berntorp E, Shapiro AD. Modern haemophilia care. Lancet. 2012;379(9824):1447-56.
Bowen DJ. Haemophilia A and haemophilia B: molecular insights. Mole Pathol. 2002;55(2):127.
Singh P, Mukherjee K. Cost-benefit analysis and assessment of quality of care in patients with hemophilia undergoing treatment at National Rural Health Mission in Maharashtra, India. Value Health Region Issues. 2017;12:101-6.
Hay CR. Prophylaxis in adults with haemophilia. Haemophilia. 2007;13:10-5.
Minno MD, Minno GD, Capua MD, Cerbone AM, Coppola A. Cost of care of haemophilia with inhibitors. Haemophilia. 2010;16(1):e190-201.
Aledort L, Bullinger M, Von Mackensen S, Wasserman J, Young NL, Globe D, et al. Why should we care about quality of life in persons with haemophilia? Haemophilia. 2012;18(3):e154-7.
Ghosh K. Management of haemophilia and its complications in developing countries. Clin Lab Haematol. 2004;26(4):243-51.
Hay CR. The epidemiology of factor VIII inhibitors. Haemophilia. 2006;12:23-9.
Franchini M, Mannucci PM. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice. Br J Clin Pharmacol. 2011;72(4):553-62.
Armstrong EP, Malone DC, Krishnan S, Wessler MJ. Costs and utilization of hemophilia A and B patients with and without inhibitors. J Med Econom. 2014;17(11):798-802.
Brown TM, Lee WC, Joshi AV, Pashos CL. Health‐related quality of life and productivity impact in haemophilia patients with inhibitors. Haemophilia. 2009;15(4):911-7.
Skinner MW. WFH: closing the global gap- achieving optimal care. Haemophilia. 2012;18:1-2.
Mannucci PM, Tuddenham EG. The hemophilias- from royal genes to gene therapy. N Engl J Med. 2001;344(23):1773-9.
Kundu T, Shaikh A, Kutty A, Nalvade A, Kulkarni S, Kulkarni R, et al. Homeopathic medicines substantially reduce the need for clotting factor concentrates in haemophilia patients: results of a blinded placebo controlled cross over trial. Homeopathy. 2012;101(01):38-43.
Kundu T, Shaik T, Singh P, Sheikh A, Kumat O. Management of acute bleeding in severe haemophilia using homeopathic medicines: a multicentric case series. J Homeop Ayurv Med. 2015;4(180):2167-206.
Kundu TK, Barde PB, Jindal GD, Motiwala FF. An exploratory study of autonomic function investigations in hemophiliacs on homoeopathy medications using impedance plethysmography. J Evid Based Complement Altern Med. 2017;22(4):760-4.
Kundu T, Ghosh K, Shaikh A, Singh P, Shaikh A, Shah H, et al. Homeopathic medicine reduces pain and hemarthrosis in moderate and severe hemophilia: a multicentric study. Complement Med Res. 2018;25(5):306-12.
Kundu TK, Khuda-Bukhsh AR. Effective management of haemophilia patients with a combined therapy to reduce cost: A new approach. Eur J Biomed Pharm Sci. 2018;5(5):748-51.
Tapas T, Omkar K, Gulfisha M. Add on homoeopathic management of a scrotal hematocele in a diagnosed severe haemophilia patient: evidence based case report. Int J Homoeopath Sci. 2020;4(4):19-22.
Shah H, Kundu T, Shaikh A. Homoeopathic management of a case of severe haemophilia type a with inhibitor positive: case report. Homoeopath Links. 2020;33(4):302-8.
Rita K, Afroz S, Tapas K, Gulfisha M, Omkar K, Kanjaksha G. Substantial reduction of cost of care of PWH by add on homoeopathic medicine reduced the parental anxiety and stress. Int J Hom Sci 2021;5(1):401-5.
Omkar K, Rita K, Prachi R, Kumar KT, Gulfisha M, Afroz S, et al. A review of usage of telemedicine for management of acute bleeding episodes in haemophilia. Int J Hom Sci. 2021;5(4):383-7.
Hiral B, Tapas K, Afroz S, Omkar K. Homoeopathic management of severe haemophilia in pediatric age group: twin case study. J Altern Complement Integr Med 2021;7:214.
Omkar K, Prapti K, Tapas K, Swarda B, Rita K. Significance of individualised homoeopathic medicine in a case of non-healing scalp wound along with standard management in moderate haemophilia B patient: a case report. Int J Creat Res Thoughts. 2022;10(6):f697-f700,
Singh P, Mukherjee K. Cost-benefit analysis and assessment of quality of care in patients with hemophilia undergoing treatment at national rural health mission in Maharashtra, India. Value Health Reg Issues. 2017;12:101-6.
